Analyst Ratings for Terns Pharmaceuticals (TERN)
TERN Rating Summary
TERN Price Target Summary
- Highest: $70.00 (Jefferies)
- Lowest: $54.00 (BMO Capital)
- Average: $58.11
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$58.11 (+35.7%)
* Over Last 12-Mos
Rating Score: 9.3 / 10
Percentile Rank: 90%
Avg. $ Target:
$58.11 (+35.7%)
* Over Last 12-Mos
Rating Score: 9.3 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/9/2026 | Leerink Partners | Andrew Berens | New Coverage | Outperform (N/A) |
58.00 (N/A) |
37.77 (42.82) |
13.37% | Details |
| 11/4/2025 | H.C. Wainwright » Updated 12/9/2025 |
Andrew Fein | Upgrade | Buy (Neutral) |
60.00 (20.00) |
14.03 (42.82) |
205.2% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
